Announcement Made Pursuant to Rule 13.51B(2) of the Listing Rules

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.APAC RESOURCES LIMITED 亚太资源有限公司* (Incorporated in Bermuda with limited liability) (Stock Code: 1104) ANNOUNCEMENT MADE PURSUANT TO RULE 13.51B(2) OF THE LISTING RULES This announcement is made by APAC Resources Limited (the “Company” together with its subsidiaries the “Group”) pursuant to Rule 13.51B(2) of the Rules Governing the Listing of Securities (the “Listing Rules”) on The Stock Exchange of Hong Kong Limited (the “StockExchange”) in relation to an update of information of Dr. Wong Wing Kuen Albert (“Dr. Wong”) an independent non-executive director of the Company.The board of directors (the “Board”) of the Company was notified by Dr. Wong that Dexin China Holdings Company Limited (“Dexin China”) an independent third party unrelated to the Group was ordered to be wound up by the High Court of The Hong Kong Special Administrative Region on 11 June 2024 and the Official Receiver was appointed as the provisional liquidator of Dexin China. Dr. Wong has been an independent non-executive director of Dexin China from 11 January 2019 up to 11 June 2024 immediately before the winding up order was granted against Dexin China.Dexin China is a company incorporated in the Cayman Islands with limited liability the shares of which are listed on the Main Board of the Stock Exchange (stock code: 2019) and have been suspended from 11 June 2024 and up to the date of this announcement. For further information regarding the winding-up of Dexin China please refer to the respective announcements of Dexin China dated 21 March 2024 5 June 2024 and 12 June 2024 published on the website of the Stock Exchange. Dr. Wong has confirmed that save as disclosed in this announcement there are no other matters which are required to be disclosed pursuant to Rules 13.51(2)(h) to (v) of the Listing Rules and he is not aware of any other matters that need to be brought to the attention of the Company and its shareholders.– 1 –The Board is of the view that the aforesaid matter does not have any impact on the business and operations of the Group nor does it affect Dr. Wong’s ability to discharge his duties as an independent non-executive director the chairman of each of the audit committee and remuneration committee of the Company and a member of the nomination committee of the Company.On behalf of the Board APAC Resources Limited Andrew Ferguson Executive Director Hong Kong 14 June 2024 As at the date of this announcement the directors of the Company are: Executive Director Mr. Andrew Ferguson (Chief Executive Officer) Non-Executive Directors Mr. Arthur George Dew (Chairman) (Mr. Wong Tai Chun Mark as his alternate) Mr. Lee Seng Hui and Ms. Lam Lin Chu Independent Non-Executive Directors Dr. Wong Wing Kuen Albert Mr. Wang Hongqian and Mr. Kelvin Chau Kwok Wing * For identification purpose only –2–